Bigul

PARNAX LAB LTD. - 506128 - Outcome Of Board Meeting

Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Friday, 31st July, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone and Consolidated Financial Results along with Auditor Report for the quarter and year ended 31st March, 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Approved Half Yearly Standalone Statement of Assets and Liabilities for year ended 31st March, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 6.30 p.m.
31-07-2020
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2020.

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
22-07-2020
Bigul

PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended June 30, 2020

Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
20-07-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, In reference to the above captioned regulation we have received confirmation from our Registrar & Transfer Agents Link Intime India Pvt. Ltd., that since there were no dematerialization requests during the quarter ended 30th June, 2020, therefore the Confirmation certificate as per Regulation 74 (5) is not applicable to the Company. This is for your information and records.
08-07-2020
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended June 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Namrata KambliDesignation :- Company Secretary and Compliance Officer
08-07-2020
Bigul

PARNAX LAB LTD. - 506128 - Closure of Trading Window

Dear Sir/Madam, Pursuant to BSE Circular dated 02nd April, 2019 vide Ref No.: List/COMP/01/2019-20 please note that trading window for dealing in the securities of the Company already closed for all Designated Persons (as defined in the code) w.e.f. 01.04 .2020 which shall continue to remain closed for the purpose of consideration of unaudited Financial Results for the quarter ended 30th June, 2020. The Trading window shall open 48 hours after the unaudited Financial Result for the quarter ended 30th June, 2020, become generally available. Kindly take the above information on your record.
30-06-2020
Bigul

PARNAX LAB LTD. - 506128 - Cancellation of Board Meeting

The Board Meeting to be held on 30/06/2020 Stands Cancelled.
24-06-2020
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2020.

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1. To approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
20-06-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliance- Compliance Certificate For The Half Year Ended 31St March, 2020

Dear Sir, Enclosed please find the Certificate as per Regulation 7(3) of the Listing Obligations for the half year ended 31st March, 2020. Kindly take the same on your record and acknowledge receipt of the same. Thanking You,
12-05-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliance- Compliance Certificate For The Half Year Ended 30Th September, 2019.

Dear Sir/Madam, Please find enclosed herewith the certificate as per Regulation 7(3) of the Listing Obligations for the half year ended 30th September, 2019. Kindly take the same on your record.
12-05-2020
Next Page
Close

Let's Open Free Demat Account